大型无蒂结直肠息肉分块内镜黏膜切除术后隐匿性黏膜下浸润癌的肿瘤学结局
本研究在大型三级转诊队列中评估分块内镜黏膜切除术(pEMR)治疗大型(>20 mm)无蒂结直肠息肉后发现的隐匿性黏膜下浸润癌(SMIC)的残留癌风险。3372例大型无蒂结直肠息肉中识别出143例隐匿性SMIC(4.2%),109例接受手术切除,98例有pEMR组织学分析。62例(63%)无残留恶性肿瘤,36例有残留恶性肿瘤(残留壁内癌24例,淋巴结转移5例,两者兼有7例)。所有残留壁内癌均可通过R1组织学深切缘识别;低分化(PD)和/或淋巴血管侵犯(LVI)者淋巴结转移风险高(12/33),无这些标准者风险极低(<1%;0/65);淋巴结转移低风险且深切缘R0者残留壁内癌风险低(<1%;0/35)。结论:多数pEMR后隐匿性SMIC无残留恶性肿瘤,残留恶性肿瘤风险可通过PD、LVI和R1深切缘三个关键变量确定。
要点
- pEMR后隐匿性SMIC中63%(62/98)无残留恶性肿瘤。
- 残留壁内癌均伴R1深切缘;PD和/或LVI者淋巴结转移风险高(12/33)。
- 无PD和LVI者淋巴结转移风险<1%(0/65)。
核心结论
- 多数pEMR后大型无蒂结直肠息肉隐匿性SMIC无残留恶性肿瘤。
- 残留恶性肿瘤风险可通过PD、LVI和R1深切缘三个关键变量确定。
研究设计与样本
- 在大型三级转诊队列中识别并随访pEMR后隐匿性SMIC病例。
- 3372例大型无蒂结直肠息肉中识别143例隐匿性SMIC(4.2%),109例接受手术切除。
- 109例中98例(90%)有pEMR组织学分析。
主要发现
- 62例(63%)无残留恶性肿瘤;36例有残留恶性肿瘤(残留壁内癌24例,淋巴结转移5例,两者兼有7例)。
- 所有残留壁内癌均可通过R1组织学深切缘识别。
- PD和/或LVI者淋巴结转移风险高(12/33),无这些标准者风险极低(<1%;0/65)。
- 淋巴结转移低风险且深切缘R0者残留壁内癌风险低(<1%;0/35)。
关键数值与推荐
- 残留恶性肿瘤风险基于pEMR组织学的PD、LVI和R1深切缘三个变量评估。
- PD和/或LVI者淋巴结转移12/33;无PD和LVI者0/65。
- 淋巴结转移低风险且R0深切缘者残留壁内癌0/35。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Management of covert submucosal invasive cancer (SMIC) discovered after piecemeal endoscopic mucosal resection (pEMR) of large (>20 mm) non-pedunculated colorectal polyps is challenging. The residual cancer risk is largely unknown. We sought to evaluate this in a large tertiary referral cohort. DESIGN: Cases of covert SMIC following pEMR were identified and followed. Oncological outcomes after surgery were divided based on residual intramural cancer, lymph node metastases (LNM) or both. Risk factors for residual intramural cancer and LNM were analysed based on the original pEMR histological variables. Risk parameters were analysed with respect to low and high-risk variables for residual intramural cancer and LNM. RESULTS: Among 3372 cases of large non-pedunculated colorectal polyps, 143 cases of covert SMIC (4.2%) were identified. 109 underwent surgical resection. Histological analysis of pEMR histology was available in 98 of 109 (90%) cases. 62 cases (63%) had no residual malignancy. 36 cases had residual malignancy (residual intramural cancer n=24; LNM n=5; both n=7). All cases of residual intramural cancer could be identified by a R1 histological deep margin. Cases with poor differentiation (PD) and/or lymphovascular invasion (LVI) had a high risk of LNM (12/33), with a very low risk without these criteria (<1%; 0/65). Cases at low risk for LNM with R0 deep margin have a low risk of residual intramural cancer (<1%; 0/35). CONCLUSION: The majority of cases of large non-pedunculated colorectal polyps with covert SMIC following pEMR will have no residual malignancy. The risk of residual malignancy can be ascertained from three key variables: PD, LVI and R1 deep margin.
引用
- Gibson DJ, Sidhu M, Zanati S, et al. Oncological outcomes after piecemeal endoscopic mucosal resection of large non-pedunculated colorectal polyps with covert submucosal invasive cancer. Gut. 2022. PMID: 35256387. doi:10.1136/gutjnl-2020-323666
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。